BUSINESS
Fuji Keizai Issues 2040 Market Outlook for Dermatology, Collagen Diseases and More
Fuji Keizai released its 2040 drug market forecast for a number of therapeutic fields on June 2 including dermatology, collagen diseases/orthopedics, and gastroenterology, which showed sharp growth particularly for atopic dermatitis therapies. The atopic dermatitis market is predicted to grow…
To read the full story
BUSINESS
- Japan Drug Makers’ H1 Sales Surge 14.7% as Weak Yen Fuels Growth
November 18, 2026
- Towa, Sawai Grow Sales on Supply Gains; Biosimilars Emerge as New Focus for Others
November 18, 2026
- Kyowa Kirin to Drop Onglyza in First for Originator DPP-4 Inhibitors
November 18, 2026
- Leqembi Sustains Benefits in Early Alzheimer’s after 5 Years of Treatment
November 18, 2026
- Meiji Invests US$50 Million in Arcturus to Expand mRNA Collaboration
November 18, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





